Elizabeth Bayliss
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deprescriptions | 11 | 2023 | 27 | 5.710 |
Why?
| Chronic Disease | 31 | 2023 | 1593 | 4.470 |
Why?
| Multiple Chronic Conditions | 11 | 2021 | 24 | 2.790 |
Why?
| Dementia | 8 | 2023 | 186 | 2.630 |
Why?
| Primary Health Care | 21 | 2022 | 1515 | 2.510 |
Why?
| Cognitive Dysfunction | 6 | 2023 | 273 | 2.490 |
Why?
| Comorbidity | 23 | 2018 | 1458 | 2.430 |
Why?
| Patient-Centered Care | 8 | 2021 | 473 | 2.040 |
Why?
| Patient Care Team | 9 | 2019 | 516 | 1.980 |
Why?
| Patient Portals | 4 | 2022 | 34 | 1.780 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 3 | 2023 | 243 | 1.580 |
Why?
| Aged | 60 | 2023 | 19122 | 1.450 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 229 | 1.450 |
Why?
| Quality of Life | 16 | 2022 | 2359 | 1.430 |
Why?
| Health Status | 8 | 2019 | 721 | 1.420 |
Why?
| Physicians, Primary Care | 7 | 2019 | 222 | 1.380 |
Why?
| Safety-net Providers | 3 | 2021 | 95 | 1.260 |
Why?
| Delivery of Health Care | 8 | 2021 | 834 | 1.210 |
Why?
| Depressive Disorder | 4 | 2012 | 332 | 1.200 |
Why?
| Continuity of Patient Care | 4 | 2019 | 254 | 1.150 |
Why?
| Quality of Health Care | 4 | 2021 | 573 | 1.080 |
Why?
| Self Care | 6 | 2012 | 350 | 1.060 |
Why?
| Aged, 80 and over | 26 | 2023 | 6364 | 1.030 |
Why?
| Mental Disorders | 6 | 2020 | 891 | 0.990 |
Why?
| Chronic Pain | 2 | 2022 | 211 | 0.970 |
Why?
| Female | 74 | 2023 | 59580 | 0.960 |
Why?
| Male | 73 | 2023 | 55663 | 0.940 |
Why?
| Communication | 7 | 2022 | 749 | 0.940 |
Why?
| Humans | 107 | 2023 | 114935 | 0.940 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 978 | 0.890 |
Why?
| Health Services | 2 | 2017 | 103 | 0.890 |
Why?
| Gastric Bypass | 2 | 2014 | 92 | 0.850 |
Why?
| Medication Adherence | 6 | 2022 | 537 | 0.810 |
Why?
| Health Status Indicators | 2 | 2014 | 154 | 0.800 |
Why?
| Retrospective Studies | 29 | 2022 | 12544 | 0.780 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 250 | 0.770 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 27 | 0.760 |
Why?
| Food Supply | 1 | 2021 | 62 | 0.740 |
Why?
| United States | 30 | 2023 | 12211 | 0.730 |
Why?
| Health Plan Implementation | 2 | 2019 | 132 | 0.720 |
Why?
| Mental Health Services | 3 | 2019 | 317 | 0.720 |
Why?
| Self Efficacy | 3 | 2019 | 355 | 0.710 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 928 | 0.690 |
Why?
| Cohort Studies | 17 | 2022 | 4903 | 0.670 |
Why?
| Advance Directives | 1 | 2020 | 69 | 0.670 |
Why?
| Medicare Part D | 2 | 2010 | 26 | 0.650 |
Why?
| Qualitative Research | 10 | 2021 | 936 | 0.650 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1400 | 0.650 |
Why?
| Middle Aged | 37 | 2021 | 26806 | 0.640 |
Why?
| Documentation | 1 | 2020 | 169 | 0.620 |
Why?
| Delayed Diagnosis | 1 | 2018 | 71 | 0.620 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 244 | 0.610 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 79 | 0.600 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 679 | 0.590 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 87 | 0.590 |
Why?
| Polypharmacy | 6 | 2023 | 74 | 0.580 |
Why?
| Time-to-Treatment | 1 | 2018 | 147 | 0.580 |
Why?
| Specialization | 2 | 2017 | 115 | 0.580 |
Why?
| Hospitalization | 6 | 2023 | 1754 | 0.570 |
Why?
| Healthcare Disparities | 2 | 2021 | 480 | 0.560 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2096 | 0.560 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1177 | 0.550 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 93 | 0.540 |
Why?
| Patient Satisfaction | 4 | 2019 | 583 | 0.540 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1183 | 0.540 |
Why?
| Adult | 31 | 2023 | 30608 | 0.540 |
Why?
| Medicaid | 2 | 2022 | 407 | 0.530 |
Why?
| Medically Uninsured | 1 | 2017 | 122 | 0.530 |
Why?
| Telemedicine | 3 | 2023 | 665 | 0.520 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1008 | 0.520 |
Why?
| Colorado | 12 | 2021 | 4091 | 0.520 |
Why?
| Patients | 2 | 2021 | 162 | 0.510 |
Why?
| Antihypertensive Agents | 5 | 2019 | 429 | 0.510 |
Why?
| Bariatric Surgery | 2 | 2015 | 161 | 0.510 |
Why?
| Pain Management | 2 | 2015 | 289 | 0.500 |
Why?
| Health Promotion | 1 | 2021 | 686 | 0.500 |
Why?
| Caregivers | 9 | 2023 | 714 | 0.500 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 4635 | 0.490 |
Why?
| Sickness Impact Profile | 2 | 2005 | 50 | 0.490 |
Why?
| Electronic Health Records | 3 | 2021 | 802 | 0.480 |
Why?
| Hypertension | 7 | 2019 | 1059 | 0.480 |
Why?
| Gastroplasty | 1 | 2014 | 26 | 0.480 |
Why?
| Diabetes Mellitus | 7 | 2017 | 904 | 0.480 |
Why?
| Health Services Accessibility | 3 | 2017 | 765 | 0.480 |
Why?
| Potentially Inappropriate Medication List | 3 | 2023 | 14 | 0.470 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 99 | 0.470 |
Why?
| Focus Groups | 5 | 2020 | 385 | 0.460 |
Why?
| Neuralgia | 1 | 2015 | 122 | 0.450 |
Why?
| Drug Utilization | 2 | 2012 | 167 | 0.450 |
Why?
| Laparoscopy | 2 | 2014 | 389 | 0.450 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1081 | 0.440 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 621 | 0.440 |
Why?
| Postoperative Care | 1 | 2015 | 220 | 0.440 |
Why?
| Morbidity | 2 | 2012 | 277 | 0.440 |
Why?
| Sleep Deprivation | 1 | 2015 | 166 | 0.440 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 130 | 0.430 |
Why?
| Cross-Sectional Studies | 14 | 2023 | 4407 | 0.420 |
Why?
| Preoperative Care | 1 | 2015 | 317 | 0.420 |
Why?
| Morphine | 1 | 2013 | 122 | 0.420 |
Why?
| Referral and Consultation | 1 | 2017 | 634 | 0.400 |
Why?
| Osteoarthritis | 3 | 2008 | 172 | 0.390 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 38 | 0.390 |
Why?
| Cluster Analysis | 2 | 2020 | 460 | 0.380 |
Why?
| Obesity | 2 | 2014 | 2514 | 0.380 |
Why?
| Severity of Illness Index | 3 | 2015 | 2542 | 0.380 |
Why?
| International Classification of Diseases | 1 | 2012 | 117 | 0.380 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 372 | 0.370 |
Why?
| Quality Improvement | 5 | 2020 | 954 | 0.370 |
Why?
| Psychotherapy | 1 | 2012 | 149 | 0.370 |
Why?
| Antidepressive Agents | 1 | 2012 | 194 | 0.370 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 925 | 0.360 |
Why?
| Physician-Patient Relations | 6 | 2019 | 463 | 0.360 |
Why?
| Office Visits | 3 | 2018 | 79 | 0.360 |
Why?
| Self Report | 5 | 2023 | 696 | 0.360 |
Why?
| Neoplasms | 3 | 2014 | 2106 | 0.350 |
Why?
| Models, Statistical | 1 | 2014 | 604 | 0.350 |
Why?
| Patient Preference | 3 | 2022 | 169 | 0.340 |
Why?
| Multimorbidity | 2 | 2021 | 33 | 0.340 |
Why?
| Perception | 3 | 2020 | 311 | 0.340 |
Why?
| Analgesics, Opioid | 2 | 2014 | 773 | 0.340 |
Why?
| Patient Participation | 5 | 2022 | 360 | 0.330 |
Why?
| Vaccination Refusal | 2 | 2021 | 69 | 0.330 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1813 | 0.330 |
Why?
| Research | 3 | 2018 | 395 | 0.320 |
Why?
| Medicare | 6 | 2023 | 666 | 0.320 |
Why?
| Risk Assessment | 7 | 2020 | 2975 | 0.320 |
Why?
| Stakeholder Participation | 2 | 2020 | 73 | 0.320 |
Why?
| Health Personnel | 3 | 2019 | 574 | 0.320 |
Why?
| Delphi Technique | 4 | 2018 | 162 | 0.310 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 300 | 0.310 |
Why?
| Disease Progression | 2 | 2015 | 2392 | 0.300 |
Why?
| Health Services for the Aged | 1 | 2008 | 70 | 0.300 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 604 | 0.290 |
Why?
| Geriatrics | 1 | 2008 | 69 | 0.290 |
Why?
| Cost of Illness | 2 | 2008 | 254 | 0.290 |
Why?
| Breast Neoplasms | 1 | 2018 | 1870 | 0.290 |
Why?
| Kidney Diseases | 1 | 2011 | 350 | 0.290 |
Why?
| Psychometrics | 3 | 2018 | 608 | 0.280 |
Why?
| Accidental Falls | 2 | 2019 | 150 | 0.270 |
Why?
| Telephone | 2 | 2017 | 152 | 0.250 |
Why?
| Parents | 3 | 2021 | 1191 | 0.240 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 1729 | 0.240 |
Why?
| Pain Measurement | 2 | 2018 | 446 | 0.240 |
Why?
| Disease Management | 4 | 2017 | 563 | 0.240 |
Why?
| Patient Compliance | 1 | 2008 | 526 | 0.240 |
Why?
| Nomograms | 2 | 2014 | 41 | 0.240 |
Why?
| Single-Payer System | 1 | 2003 | 2 | 0.230 |
Why?
| National Health Insurance, United States | 1 | 2003 | 5 | 0.230 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 48 | 0.230 |
Why?
| Death | 2 | 2022 | 107 | 0.230 |
Why?
| Vaccination | 3 | 2021 | 1205 | 0.230 |
Why?
| Dyslipidemias | 3 | 2019 | 154 | 0.230 |
Why?
| Multivariate Analysis | 5 | 2013 | 1440 | 0.230 |
Why?
| Managed Care Programs | 2 | 2014 | 133 | 0.220 |
Why?
| Health Services Research | 3 | 2017 | 371 | 0.220 |
Why?
| Prognosis | 4 | 2014 | 3344 | 0.220 |
Why?
| Inappropriate Prescribing | 1 | 2023 | 52 | 0.210 |
Why?
| Insurance Coverage | 2 | 2018 | 202 | 0.210 |
Why?
| Data Collection | 1 | 2005 | 623 | 0.210 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 185 | 0.210 |
Why?
| Health Care Reform | 1 | 2003 | 92 | 0.210 |
Why?
| Attitude | 2 | 2021 | 228 | 0.210 |
Why?
| Asthma | 2 | 2016 | 2042 | 0.210 |
Why?
| Physicians | 2 | 2023 | 772 | 0.200 |
Why?
| Survival Rate | 3 | 2014 | 1644 | 0.200 |
Why?
| Proxy | 1 | 2021 | 23 | 0.190 |
Why?
| Longitudinal Studies | 4 | 2018 | 2382 | 0.190 |
Why?
| Age Factors | 6 | 2019 | 2891 | 0.180 |
Why?
| Maryland | 1 | 2020 | 37 | 0.180 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 108 | 0.180 |
Why?
| Patient Care Management | 1 | 2020 | 54 | 0.180 |
Why?
| Child, Preschool | 5 | 2021 | 9086 | 0.180 |
Why?
| Clergy | 1 | 2020 | 12 | 0.170 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 83 | 0.170 |
Why?
| Residence Characteristics | 1 | 2022 | 275 | 0.170 |
Why?
| Health Surveys | 3 | 2012 | 443 | 0.170 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 169 | 0.170 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.170 |
Why?
| Follow-Up Studies | 4 | 2017 | 4427 | 0.170 |
Why?
| Southwestern United States | 1 | 2019 | 91 | 0.170 |
Why?
| Urban Health Services | 1 | 2019 | 60 | 0.170 |
Why?
| Time Factors | 5 | 2018 | 6125 | 0.170 |
Why?
| Interprofessional Relations | 2 | 2013 | 251 | 0.170 |
Why?
| Religion | 1 | 2019 | 64 | 0.160 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.160 |
Why?
| Attitude to Health | 2 | 2015 | 406 | 0.160 |
Why?
| Comprehensive Health Care | 2 | 2017 | 19 | 0.160 |
Why?
| Young Adult | 6 | 2016 | 10478 | 0.150 |
Why?
| Mastectomy | 1 | 2018 | 99 | 0.150 |
Why?
| Contraindications, Drug | 1 | 2018 | 6 | 0.150 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 182 | 0.150 |
Why?
| Vaccines | 2 | 2020 | 376 | 0.150 |
Why?
| Prospective Studies | 5 | 2023 | 6218 | 0.150 |
Why?
| Medical Informatics | 1 | 2019 | 92 | 0.150 |
Why?
| Interviews as Topic | 3 | 2016 | 582 | 0.150 |
Why?
| Models, Theoretical | 1 | 2021 | 516 | 0.150 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 333 | 0.150 |
Why?
| Blood Pressure | 3 | 2019 | 1537 | 0.140 |
Why?
| Independent Living | 1 | 2018 | 84 | 0.140 |
Why?
| SEER Program | 2 | 2014 | 196 | 0.140 |
Why?
| Adolescent | 6 | 2015 | 17829 | 0.140 |
Why?
| Logistic Models | 5 | 2013 | 1844 | 0.140 |
Why?
| Body Mass Index | 2 | 2014 | 1961 | 0.140 |
Why?
| Case Management | 1 | 2017 | 62 | 0.140 |
Why?
| Electronics | 1 | 2017 | 66 | 0.140 |
Why?
| General Practice | 1 | 2016 | 27 | 0.140 |
Why?
| Schools | 1 | 2019 | 400 | 0.130 |
Why?
| Influenza Vaccines | 1 | 2021 | 497 | 0.130 |
Why?
| Medication Therapy Management | 1 | 2017 | 67 | 0.130 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 122 | 0.130 |
Why?
| Health Care Costs | 1 | 2019 | 380 | 0.130 |
Why?
| Infant | 2 | 2021 | 7937 | 0.130 |
Why?
| Validation Studies as Topic | 1 | 2015 | 23 | 0.130 |
Why?
| Metformin | 1 | 2019 | 278 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 546 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2018 | 269 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2018 | 1180 | 0.120 |
Why?
| Hyperlipidemias | 2 | 2012 | 122 | 0.120 |
Why?
| Child | 5 | 2021 | 18366 | 0.120 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1080 | 0.120 |
Why?
| Research Design | 1 | 2020 | 932 | 0.120 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 9 | 0.120 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 756 | 0.110 |
Why?
| Health Priorities | 1 | 2014 | 34 | 0.110 |
Why?
| Activities of Daily Living | 2 | 2008 | 350 | 0.110 |
Why?
| Health Education | 1 | 2016 | 322 | 0.110 |
Why?
| Cooperative Behavior | 2 | 2014 | 383 | 0.110 |
Why?
| Risk Factors | 6 | 2023 | 8637 | 0.110 |
Why?
| Postoperative Complications | 2 | 2014 | 2133 | 0.110 |
Why?
| Age Distribution | 1 | 2014 | 340 | 0.110 |
Why?
| Decision Making | 1 | 2019 | 781 | 0.110 |
Why?
| Depression | 3 | 2018 | 1134 | 0.110 |
Why?
| Guideline Adherence | 1 | 2017 | 490 | 0.110 |
Why?
| Terminally Ill | 1 | 2013 | 33 | 0.100 |
Why?
| Postoperative Period | 1 | 2013 | 289 | 0.100 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 40 | 0.100 |
Why?
| Information Dissemination | 1 | 2014 | 188 | 0.100 |
Why?
| Program Evaluation | 1 | 2017 | 824 | 0.100 |
Why?
| Insulin | 2 | 2019 | 2079 | 0.100 |
Why?
| Obesity, Morbid | 1 | 2014 | 197 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 313 | 0.100 |
Why?
| Secondary Prevention | 1 | 2013 | 221 | 0.100 |
Why?
| Diabetes Complications | 1 | 2013 | 211 | 0.090 |
Why?
| Primary Prevention | 1 | 2013 | 171 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 128 | 0.090 |
Why?
| Data Mining | 1 | 2011 | 100 | 0.090 |
Why?
| Weight Loss | 1 | 2015 | 642 | 0.090 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 213 | 0.090 |
Why?
| Databases, Factual | 2 | 2012 | 1125 | 0.090 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 107 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 675 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2770 | 0.080 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 246 | 0.080 |
Why?
| Prescription Fees | 1 | 2008 | 3 | 0.080 |
Why?
| Treatment Outcome | 4 | 2016 | 9105 | 0.080 |
Why?
| Autoimmune Diseases | 1 | 2012 | 392 | 0.080 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 90 | 0.080 |
Why?
| Poisson Distribution | 1 | 2008 | 72 | 0.080 |
Why?
| Self Disclosure | 1 | 2008 | 59 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 57 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2316 | 0.080 |
Why?
| Pain | 1 | 2014 | 710 | 0.080 |
Why?
| Biomedical Research | 1 | 2014 | 585 | 0.080 |
Why?
| Eligibility Determination | 1 | 2008 | 60 | 0.080 |
Why?
| Community Health Services | 1 | 2010 | 212 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2012 | 776 | 0.070 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 413 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3248 | 0.070 |
Why?
| Treatment Refusal | 1 | 2007 | 85 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2012 | 607 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 954 | 0.070 |
Why?
| Sex Distribution | 1 | 2007 | 336 | 0.070 |
Why?
| Mass Screening | 1 | 2013 | 1011 | 0.070 |
Why?
| Urban Population | 2 | 2012 | 402 | 0.070 |
Why?
| California | 2 | 2020 | 363 | 0.060 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1270 | 0.060 |
Why?
| Linear Models | 1 | 2007 | 770 | 0.060 |
Why?
| Chicago | 1 | 2004 | 45 | 0.060 |
Why?
| Los Angeles | 1 | 2004 | 56 | 0.060 |
Why?
| Boston | 1 | 2004 | 75 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1474 | 0.060 |
Why?
| Pandemics | 2 | 2023 | 1325 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 214 | 0.060 |
Why?
| Social Support | 1 | 2007 | 528 | 0.060 |
Why?
| Goals | 1 | 2005 | 151 | 0.060 |
Why?
| Choice Behavior | 1 | 2005 | 155 | 0.060 |
Why?
| Medicine | 1 | 2004 | 102 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 947 | 0.050 |
Why?
| Internet | 2 | 2019 | 599 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 307 | 0.050 |
Why?
| Housing | 1 | 2022 | 114 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 67 | 0.050 |
Why?
| Washington | 1 | 2021 | 133 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2012 | 495 | 0.050 |
Why?
| Health Expenditures | 1 | 2022 | 171 | 0.050 |
Why?
| Medical Records | 1 | 2021 | 154 | 0.050 |
Why?
| Health Care Rationing | 1 | 2020 | 45 | 0.050 |
Why?
| Resource Allocation | 1 | 2020 | 37 | 0.050 |
Why?
| Assisted Living Facilities | 1 | 2020 | 9 | 0.040 |
Why?
| Minority Groups | 1 | 2022 | 228 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 106 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 1952 | 0.040 |
Why?
| Health Behavior | 1 | 2005 | 704 | 0.040 |
Why?
| Social Determinants of Health | 1 | 2021 | 135 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 945 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 136 | 0.040 |
Why?
| Mortality | 1 | 2020 | 288 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 73 | 0.040 |
Why?
| Medicare Part C | 1 | 2019 | 25 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 741 | 0.040 |
Why?
| Intention | 1 | 2019 | 143 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 257 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 296 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 954 | 0.030 |
Why?
| Guidelines as Topic | 1 | 2018 | 244 | 0.030 |
Why?
| Prevalence | 1 | 2022 | 2252 | 0.030 |
Why?
| Automation | 1 | 2016 | 73 | 0.030 |
Why?
| Drug Interactions | 1 | 2017 | 347 | 0.030 |
Why?
| Hospitals | 1 | 2020 | 581 | 0.030 |
Why?
| Consensus | 1 | 2018 | 534 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 232 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 546 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1227 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 448 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 20 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 559 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 54 | 0.030 |
Why?
| Biomarkers | 2 | 2013 | 3418 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 42 | 0.030 |
Why?
| Forecasting | 1 | 2014 | 333 | 0.030 |
Why?
| Turkey | 1 | 2012 | 14 | 0.030 |
Why?
| Etanercept | 1 | 2012 | 51 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 846 | 0.030 |
Why?
| London | 1 | 2012 | 42 | 0.020 |
Why?
| Needs Assessment | 1 | 2014 | 315 | 0.020 |
Why?
| Infliximab | 1 | 2012 | 94 | 0.020 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 77 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 139 | 0.020 |
Why?
| United Kingdom | 1 | 2012 | 227 | 0.020 |
Why?
| Reoperation | 1 | 2013 | 515 | 0.020 |
Why?
| Immunologic Factors | 1 | 2012 | 221 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 255 | 0.020 |
Why?
| Risk | 1 | 2012 | 815 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 635 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 140 | 0.020 |
Why?
| Aging | 1 | 2018 | 1621 | 0.020 |
Why?
| Empathy | 1 | 2010 | 138 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 608 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 8 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1134 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1721 | 0.020 |
Why?
| Veterans | 1 | 2017 | 1240 | 0.020 |
Why?
| Learning | 1 | 2010 | 352 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 6 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 73 | 0.020 |
Why?
| Registries | 1 | 2012 | 1760 | 0.020 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 83 | 0.010 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 64 | 0.010 |
Why?
| Patient Care Planning | 1 | 2005 | 139 | 0.010 |
Why?
| Fruit | 1 | 2005 | 128 | 0.010 |
Why?
| Vegetables | 1 | 2005 | 133 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2005 | 678 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1643 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|